Literature DB >> 12782352

Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea.

Keiji Tabuchi1, Keiko Oikawa, Isao Uemaetomari, Shigeki Tsuji, Tetsuro Wada, Akira Hara.   

Abstract

This study aimed to evaluate the effects of steroidal drugs on the functional recovery of the cochlea after transient ischemia. Albino guinea pigs were subjected to transient cochlear ischemia of 30 min duration, and the threshold shifts of the compound action potential (CAP) from the pre-ischemic values were evaluated 4 h after ischemia. Pre-ischemic administration of a glucocorticoid, prednisolone or methylprednisolone, significantly ameliorated the post-ischemic CAP threshold shifts as compared with control animals at a relatively wide range of doses. Post-ischemic administration of these glucocorticoids also exhibited protective effects. Pre-ischemic administration of dehydroepiandrosterone sulfate significantly decreased the post-ischemic CAP threshold shifts 4 h after ischemia. The present results indicate that glucocorticoids and dehydroepiandrosterone sulfate possess therapeutic effects against ischemic injury of the cochlea, such as idiopathic sudden sensorineural hearing loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782352     DOI: 10.1016/s0378-5955(03)00078-9

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  11 in total

Review 1.  Mechanisms of noise-induced hearing loss indicate multiple methods of prevention.

Authors:  Colleen G Le Prell; Daisuke Yamashita; Shujiro B Minami; Tatsuya Yamasoba; Josef M Miller
Journal:  Hear Res       Date:  2006-12-04       Impact factor: 3.208

2.  Combined Intratympanic and Systemic Steroid Therapy in Sudden Sensorineural Hearing Loss.

Authors:  Sukhdev Khadav; Pooja Arya; Gaurav Gupta; Deep Chand; Ramchander Bishnoi; Devendra Singh Chawra
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-08-25

3.  Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.

Authors:  Haralampos Gouveris; Oksana Selivanova; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

Review 4.  Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.

Authors:  Tomás Labatut; María José Daza; Antonio Alonso
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

5.  Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species.

Authors:  Keiji Tabuchi; Bungo Nishimura; Shuho Tanaka; Kentaro Hayashi; Yuki Hirose; Akira Hara
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

Review 6.  Effects of NSAIDs on the Inner Ear: Possible Involvement in Cochlear Protection.

Authors:  Tomofumi Hoshino; Keiji Tabuchi; Akira Hara
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-27

7.  Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss.

Authors:  Nezamoddin Berjis; Saeed Soheilipour; Alireza Musavi; Seyed Mostafa Hashemi
Journal:  Adv Biomed Res       Date:  2016-06-20

8.  Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy.

Authors:  Emanuele Ferri; Antonio Frisina; Anna Chiara Fasson; Enrico Armato; Giacomo Spinato; Maurizio Amadori
Journal:  ISRN Otolaryngol       Date:  2012-02-19

9.  Risk of sudden sensorineural hearing loss in stroke patients: A 5-year nationwide investigation of 44,460 patients.

Authors:  Chin-Lung Kuo; An-Suey Shiao; Shuu-Jiun Wang; Wei-Pin Chang; Yung-Yang Lin
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

10.  Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: Meta-analysis of randomized controlled trials.

Authors:  Dan Lai; Fei Zhao; Nasim Jalal; Yun Zheng
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.